FUNDING OPPORTUNITIES from the Department of Health and Human Services (DHHS)
________________________________________________________
Department of Health and Human Services – Agency for Health Care Research and Quality – Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 – Clinical Trial Optional)
Proposal Due Date: July 17, 2024
Expected Number of Awards:
Estimated Total Program Funding:
Award Ceiling:
Award Floor:
Funding Opportunity Number: PA-21-164
Purpose: This FOA invites applications that propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities.
https://www.grants.gov/web/grants/view-opportunity.html?oppId=331398
________________________________________________________
Department of Health and Human Services – Centers for Disease Control and Prevention – ERA – Research Grants to Develop or Identify Effective Strategies to Prevent Overdose Involving Illicit Stimulants and Polysubstance Use Involving Stimulants
Proposal Due Date: April 12, 2021
Expected Number of Awards: 8
Estimated Total Program Funding: $13,050,000
Award Ceiling: $725,000
Award Floor:
Funding Opportunity Number: RFA-CE-21-002
Purpose: The Centers for Disease Control and Prevention (CDC) National Center for Injury Prevention and Control (NCIPC) is soliciting investigator-initiated research that will support the identification of effective strategies for state, community, or systems-level implementation to prevent fatal and nonfatal overdoses involving illicit stimulants (e.g., methamphetamine and cocaine) as well as polysubstance use and overdose involving illicit stimulants. This Notice of Funding Opportunity (NOFO) is intended to support research on one of the following two Objectives:
Objective 1: Conduct a process and outcome evaluation of new or adapted strategies, programs, or policies that can be implemented at the state, community, or systems-level to prevent illicit stimulant use or fatal and nonfatal overdose involving illicit stimulants, or polysubstance use or overdose involving illicit stimulants, OR
Objective 2: Assess risk and protective factors for illicit stimulant use, use disorder, and overdose that can contribute to the development or adaptation of intervention strategies.
https://www.grants.gov/web/grants/view-opportunity.html?oppId=329359
________________________________________________________
Department of Health and Human Services – Centers for Disease Control and Prevention – ERA – Underground Mine Evacuation Technologies and Human Factors Research
Proposal Due Date: February 1, 2022
Expected Number of Awards: 1
Estimated Total Program Funding: $1,000,000
Award Ceiling: $1,000,000
Award Floor: $775,000
Funding Opportunity Number: RFA-OH-21-006
Purpose: The purpose of this funding opportunity announcement (FOA) is to provide grant opportunities to universities with graduate programs in mining and explosives engineering to 1) support research related to mine emergencies, and 2) build on the work of the National Institute for Occupational Safety and Health (NIOSH) to address mandates in the Mine Improvement and New Emergency Response Act of 2006 (P.L. 109-236). Research priorities include: developing new wireless communication devices and methodologies; developing training, systems, and tools to facilitate miner self-escape; and continuing to improve the design of refuge alternatives. Other possible research areas of interest may include other health and safety issues in related areas, particularly those related to mine emergencies caused by mine fires and explosions. Interested applicants are encouraged to consider aspects of their graduate program in mining and explosives engineering, including unique facilities, that could best support research related to mine emergencies.
https://www.grants.gov/web/grants/view-opportunity.html?oppId=328769
________________________________________________________
Department of Health and Human Services – National Institutes of Health – NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional)
Proposal Due Date: April 13, 2021
Expected Number of Awards:
Estimated Total Program Funding:
Award Ceiling:
Award Floor:
Funding Opportunity Number: PAR-20-319
Purpose: The purpose of this FOA is the rapid and efficient translation of innovative laboratory research findings into therapies, devices or other resources for use by clinicians to treat visual system diseases or disorders. Multidisciplinary teams of scientists and clinicians will focus on generating preclinical data that will lead to the development of biological interventions, such as gene therapy, cell-based therapy, pharmacological approaches, and/or medical devices. The ultimate goal of this program is to make technological, biological and pharmacological resources available to clinicians and their patients.
https://grants.nih.gov/grants/guide/pa-files/PAR-20-319.html
________________________________________________________
Department of Health and Human Services – National Institutes of Health – Basic Research to Inform Vaccine and Therapeutic Development for Non-Polio Human Enteroviruses (NPEV) (R01 Clinical Trial Not Allowed)
Letter of Intent Due Date: 30 days prior to application due date
Proposal Due Date: July 13, 2021
Expected Number of Awards:
Estimated Total Program Funding:
Award Ceiling:
Award Floor:
Funding Opportunity Number: RFA-AI-21-006
Purpose: The purpose of this funding opportunity announcement is to solicit applications to expand basic research on non-polio enteroviruses (NPEV) that will inform the development of pan-enterovirus vaccines and broad-spectrum antivirals against enteroviruses A, B, C, and D.
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-006.html